vs
Side-by-side financial comparison of Cardiff Oncology, Inc. (CRDF) and HWH International Inc. (HWH). Click either name above to swap in a different company.
Cardiff Oncology, Inc. is the larger business by last-quarter revenue ($243.0K vs $206.8K, roughly 1.2× HWH International Inc.). HWH International Inc. runs the higher net margin — -140.7% vs -2969.5%, a 2828.8% gap on every dollar of revenue. On growth, Cardiff Oncology, Inc. posted the faster year-over-year revenue change (62.0% vs -40.2%).
HWH International Inc operates in the global luxury hospitality and lifestyle services industry, providing premium travel membership programs, curated high-end travel experiences, and exclusive access to luxury resorts, fine dining venues, and premium leisure facilities. Its key markets include North America, Asia Pacific, and Europe, serving high-net-worth individuals and corporate clients.
CRDF vs HWH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $243.0K | $206.8K |
| Net Profit | $-7.2M | $-291.0K |
| Gross Margin | — | 59.8% |
| Operating Margin | -3221.0% | -142.7% |
| Net Margin | -2969.5% | -140.7% |
| Revenue YoY | 62.0% | -40.2% |
| Net Profit YoY | 38.8% | 46.9% |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $243.0K | — | ||
| Q3 25 | $120.0K | $206.8K | ||
| Q2 25 | $121.0K | $310.4K | ||
| Q1 25 | $109.0K | — | ||
| Q4 24 | $150.0K | $287.1K | ||
| Q3 24 | $165.0K | $345.5K | ||
| Q2 24 | $163.0K | $334.9K | ||
| Q1 24 | $205.0K | $286.1K |
| Q4 25 | $-7.2M | — | ||
| Q3 25 | $-11.3M | $-291.0K | ||
| Q2 25 | $-13.9M | $83.4K | ||
| Q1 25 | $-13.4M | — | ||
| Q4 24 | $-11.8M | $-476.7K | ||
| Q3 24 | $-11.9M | $-548.5K | ||
| Q2 24 | $-11.8M | $-387.9K | ||
| Q1 24 | $-10.0M | $-1.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | 59.8% | ||
| Q2 25 | — | 48.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 39.6% | ||
| Q3 24 | — | 46.3% | ||
| Q2 24 | — | 49.2% | ||
| Q1 24 | — | 57.1% |
| Q4 25 | -3221.0% | — | ||
| Q3 25 | -9978.3% | -142.7% | ||
| Q2 25 | -12212.4% | 24.5% | ||
| Q1 25 | -13194.5% | — | ||
| Q4 24 | -8381.3% | -170.2% | ||
| Q3 24 | -7637.0% | -155.5% | ||
| Q2 24 | -7696.3% | -120.5% | ||
| Q1 24 | -5333.2% | -467.1% |
| Q4 25 | -2969.5% | — | ||
| Q3 25 | -9381.7% | -140.7% | ||
| Q2 25 | -11523.1% | 26.9% | ||
| Q1 25 | -12324.8% | — | ||
| Q4 24 | -7858.0% | -166.1% | ||
| Q3 24 | -7184.8% | -158.7% | ||
| Q2 24 | -7225.8% | -115.8% | ||
| Q1 24 | -4883.4% | -467.2% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.17 | — | ||
| Q2 25 | $-0.21 | — | ||
| Q1 25 | $-0.20 | — | ||
| Q4 24 | $-0.22 | — | ||
| Q3 24 | $-0.25 | — | ||
| Q2 24 | $-0.26 | — | ||
| Q1 24 | $-0.22 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $58.3M | $2.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $45.4M | $2.8M |
| Total Assets | $61.9M | $5.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $58.3M | — | ||
| Q3 25 | $60.6M | $2.9M | ||
| Q2 25 | $71.0M | $3.7M | ||
| Q1 25 | $79.9M | — | ||
| Q4 24 | $91.7M | $4.4M | ||
| Q3 24 | $57.7M | $836.3K | ||
| Q2 24 | $60.3M | $958.9K | ||
| Q1 24 | $67.2M | $1.1M |
| Q4 25 | $45.4M | — | ||
| Q3 25 | $48.8M | $2.8M | ||
| Q2 25 | $58.6M | $3.2M | ||
| Q1 25 | $70.9M | — | ||
| Q4 24 | $82.9M | $2.8M | ||
| Q3 24 | $49.4M | $-374.9K | ||
| Q2 24 | $52.4M | $-3.6M | ||
| Q1 24 | $60.9M | $-3.1M |
| Q4 25 | $61.9M | — | ||
| Q3 25 | $63.8M | $5.2M | ||
| Q2 25 | $75.7M | $10.6M | ||
| Q1 25 | $84.8M | — | ||
| Q4 24 | $97.2M | $6.4M | ||
| Q3 24 | $62.9M | $2.9M | ||
| Q2 24 | $66.1M | $3.1M | ||
| Q1 24 | $74.0M | $2.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $-199.9K |
| Free Cash FlowOCF − Capex | — | $-217.9K |
| FCF MarginFCF / Revenue | — | -105.4% |
| Capex IntensityCapex / Revenue | — | 8.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $-10.8M | $-199.9K | ||
| Q2 25 | $-8.3M | $26.9K | ||
| Q1 25 | $-12.8M | — | ||
| Q4 24 | $-10.3M | $-415.2K | ||
| Q3 24 | $-10.5M | $-275.0K | ||
| Q2 24 | $-9.2M | $-490.8K | ||
| Q1 24 | $-7.7M | $-638.2K |
| Q4 25 | — | — | ||
| Q3 25 | $-10.9M | $-217.9K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-415.5K | ||
| Q3 24 | — | $-277.1K | ||
| Q2 24 | — | $-516.8K | ||
| Q1 24 | $-7.8M | $-640.3K |
| Q4 25 | — | — | ||
| Q3 25 | -9043.3% | -105.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -144.7% | ||
| Q3 24 | — | -80.2% | ||
| Q2 24 | — | -154.3% | ||
| Q1 24 | -3814.6% | -223.8% |
| Q4 25 | — | — | ||
| Q3 25 | 15.0% | 8.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | 0.0% | 7.7% | ||
| Q1 24 | 39.0% | 0.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.32× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
